ST-1499 antibody therapy offers unique hope in treating covid-19 patients. The therapy is being developed by a California bio-medical company Sorrento. The company has a huge anti-body library where it has been screening billions of anti-bodies and has recently found several that have promising blocking capabilities to inhibit Sars-Cov-2 infection. The ST-1499 per the company has stood out to completely block the SARS-Cov-2 infection. Sorrento is moving forward rapidly to have this treatment available to the public. The pre-clinical experiments on ST-1499 would have to go through appropriate trials and necessary regulatory approvals. Details of the study outcome are available here. TexasCovid19 will continue to monitor promising treatments such as ST-1499 and will update viewers as the information becomes available.